JWilde
Long

TNXP - P&L Projection

NASDAQ:TNXP   TONIX PHARMACEUTICALS HLDG COR
25 0 4
Ticker gaining positive sentiment over the weekend. FDA approval expected in Sept. after previously submitted positive Phase 3 results. Current PPS shows minimum R/R Ratio of 2.71. Will be looking to open half position swing entry at $2.20 and completing fill > $2.90.
Ideas Scripts Chart
United States
United Kingdom
India
España
France
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out